~~<i id='27B39D38FA'><strike id='27B39D38FA'><tt id='27B39D38FA'><pre id='27B39D38FA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：comprehensive 2025-09-27 18:53:36 - browse：988

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Care demand spikes challenge UnitedHealth’s provider arm

Wikipedia

knowledge

focus

explore

entertainment

PabloMartinezMonsivais/APRoughly33.4millionadultsolderthan65andpeoplewithdisabilitieswereenrolledina

WSS

Secretariat’s lessons for human medicine

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Weight loss drugs aren’t covered by Obamacare. That may change

Abridge raises $150m as clinical notes automation market heats up

Europe sees delivery challenges ahead on Alzheimer's therapies

Care demand spikes challenge UnitedHealth’s provider arm

hotspot

leisure time

Wikipedia

Activists slam private health insurers over coverage restrictions

Measles policy set amid Florida outbreak alarms vaccine proponents

New air purifier tech could be key to improving indoor air quality

Abridge raises $150m as clinical notes automation market heats up

Wildfire smoke exposes gaps in outdoor worker protections

Involuntary treatment for addiction doesn't work

Hollywood unions extend contract negotiations for actors

Federal judge rules Oregon’s tough new gun law is constitutional

Malaria cases in Florida and Texas: Here’s what you need to know

Opioid cravings were reduced by anti

knowledge

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Congress may force more Covid

New CMS data security rules will hurt Medicare, Medicaid research

knowledge

focus

explore

entertainment